A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cancer. Basic parameters: 18 years — 120 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients
Overview
This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.
Detailed description
This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.
Primary outcome measures
- Treatment Effectiveness - Time to treatment discontinuation [Time frame: This is an open-ended registry where data will be collected, analysed and presented regularly over time.]
Eligibility criteria
Inclusion criteria
Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent
Exclusion criteria
Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United States · 7 centers
- Pacific Cancer Care — Monterey
- Bayhealth Cancer Center-Kent — Dover
- Bayhealth Cancer Center- Sussex — Milford
- Northwest Oncology & Hematology — Elk Grove Village
- New Mexico Oncology Hematology Consultants — Albuquerque
- Lankenau Medical Center — Paoli
- Oncology Consultants, P.A. — Houston
Identifiers
NCT: NCT06877884 · NPM-001